<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B71DAB15-F1C8-4390-83FE-32E90E74FE79"><gtr:id>B71DAB15-F1C8-4390-83FE-32E90E74FE79</gtr:id><gtr:name>Ministry of Defence (MOD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1529782F-9068-4364-888E-46E4FC4881F5"><gtr:id>1529782F-9068-4364-888E-46E4FC4881F5</gtr:id><gtr:name>Nottingham Trent University</gtr:name><gtr:address><gtr:line1>Burton Street</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG1 4BU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:department>Norwich Medical School</gtr:department><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B71DAB15-F1C8-4390-83FE-32E90E74FE79"><gtr:id>B71DAB15-F1C8-4390-83FE-32E90E74FE79</gtr:id><gtr:name>Ministry of Defence (MOD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1529782F-9068-4364-888E-46E4FC4881F5"><gtr:id>1529782F-9068-4364-888E-46E4FC4881F5</gtr:id><gtr:name>Nottingham Trent University</gtr:name><gtr:address><gtr:line1>Burton Street</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG1 4BU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3855689D-5CD4-48B8-BDD8-DECAC181082E"><gtr:id>3855689D-5CD4-48B8-BDD8-DECAC181082E</gtr:id><gtr:firstName>William</gtr:firstName><gtr:otherNames>Duncan</gtr:otherNames><gtr:surname>Fraser</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801462"><gtr:id>21944A42-46DA-49C7-92FE-D9F7153C00E3</gtr:id><gtr:title>Biochemical Markers of Bone Metabolism and Paget s Disease of Bone</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801462</gtr:grantReference><gtr:abstractText>Biochemical markers of bone metabolism are easily measured in either blood or urine samples. Identification of the best of these biomarkers that is able to detect bone disease,correlate with severity of disease and predict response to therapy in metabolic bone disease would be a major advantage to clinicians looking after patients with these diseases. The recently completed PRISM and the ongoing PRISM EZ study have provided a unique clinical data set in the largest population of patients with Paget s disease ever treated as part of a clinical trial. We will measure several new and established biochemical markers of bone metabolism in samples obtained from patients who completed the PRISM study and in those continuing within PRISM EZ and hope to identify which marker(s) best diagnose the condition, correlate with disease severity, predict a good response to treatment, failure of treatment, whether within the symptomatic treatment or intensive treatment arms of the trial patients can be identified by biomarkers that are non responders to treatment and whether these biomarkers correlate better than the currently used marker (ALP) with the clinical outcome. Identifying a biochemical marker(s) that predicts clinical outcome would help the early identification of patients who may respond to specific therapeutic approaches that may prevent unnecessary treatment and waste of valuable clinical resources.</gtr:abstractText><gtr:technicalSummary>Measurement of biochemical markers of bone metabolism in plasma/urine, that reflect osteoclast or osteoblast number and function, offers the potential for convenient rapid assessment of:
(1) extent and severity of metabolic bone disease 
(2) requirement for therapy 
(3) prediction of therapeutic outcomes
(4) requirement for a change of therapy. 
Paget s Disease of Bone (PDB) is a model disease to study these biomarkers because both the osteoclast and osteoblast are involved in the pathological process. Newer biomarkers may have advantages in PDB through their cell specificity and reflection of type I collagen metabolism . 
We will measure the following bone biomarkers in 9,600 samples obtained from PDB patients who have taken part in the PRISM studies-
Osteoclast Markers 
C-terminal cross-linking telopeptide of type I collagen
Tartrate?resistant acid phosphatase type 5b 
Urine N-terminal cross-linking telopeptide of type I collagen 
Urine pyridinoline and deoxypyridinoline 
Osteoblast Markers
Bone Specific Alkaline Phosphatase
Procollagen type I N propeptide (trimer) 
Procollagen type I N propeptide (monomer) 
Regulatory Molecules
Osteoprotegerin 
Soluble Receptor Activitor of NF kappa B Ligand 
Each marker will be evaluated using appropriate statistical analysis in terms of:
(1) diagnosis of Paget?s disease at baseline.
(2) correlations with disease extent and activity
(3) changes with treatment 
(4) whether clinical changes correlate with alterations in markers
(5) whether markers can predict good or poor response to therapy
(6) the best marker to identify patients relapsing biochemically prior to clinical relapse 
(7) outcome related differences between the two treatment groups.
The PRISM trial is a pragmatic, randomised controlled trial in 1331 patients with PDB . Patients were randomised to either the ?intensive? group where the aim was to normalise total ALP with bisphosphonate therapy or ?symptomatic? who were treated only if they had bone pain. Bisphosphonates were given in this group if analgesics/anti-inflammatory drugs were ineffective. PRISM includes 4226 patient years of exposure to treatment and 3 years average follow-up. PRISM has been extended with the ongoing PRISM-EZ trial. The PRISM cohort has been extensively characterised in terms of disease activity,skeletal involvement, bone deformity and other features of the disease providing unique insight into the natural history of the disease. At baseline the PRISM cohort closely reflected the clinical workload for physicians treating PDB. Comprehensive information on disease distribution (isotope bone scan), previous treatment, skeletal complications (joint replacements, fractures, orthopaedic procedures), routine biochemistry,haematology,skeletal radiographs (pelvis, weight bearing lower limbs) and audiograms (where skull involved) is available making this a unique data set for evaluating biomarkers of bone metabolism.</gtr:technicalSummary><gtr:fund><gtr:end>2013-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>890742</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nottingham Trent University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Vitamin D in Athletes</gtr:description><gtr:id>99DE254C-4FDD-4FA1-8760-5BEED95DF87A</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>h5YTdHVkZfY-1</gtr:outcomeId><gtr:partnerContribution>proposal contribution, PhD candidate subject recruitment and study</gtr:partnerContribution><gtr:piContribution>Joint work proposal, biochemical analysis PhD supervision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical School</gtr:department><gtr:description>Measurement of Vitamin D and Bone Markers in the ALSPAC Cohort</gtr:description><gtr:id>CE1B4F9C-B6FD-487B-8473-9511AAF6153C</gtr:id><gtr:impact>Grant awards, peer reviewed publications, review articles, contribution to national guidelines.</gtr:impact><gtr:outcomeId>546486a826b9f6.61088297-1</gtr:outcomeId><gtr:partnerContribution>Formulation and design of experiments, collection of samples, writing and reviewing manuscripts, sponsor of studies.</gtr:partnerContribution><gtr:piContribution>Measurement of Vitamin D by Tandem MS. Measurement of bone markers and calcium related control molecules. Contribution to writing and reviewing manuscripts</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nottingham Trent University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Bone Metabolism in Athletes</gtr:description><gtr:id>63CEBBA5-5509-4171-88E5-D754356B01A9</gtr:id><gtr:impact>PhDs x2, 1 awarded 1 on-going, Peer reviewed publications, Review articles, Grant awards, University promotion (NottinghamTrent).</gtr:impact><gtr:outcomeId>5464901112a715.77376014-1</gtr:outcomeId><gtr:partnerContribution>Formulation of protocols and studies, recruitment of subjects into studies, sampling during and after exercise protocols genetic analysis, ariting and review of manuscripts, collaboration on grant applications.</gtr:partnerContribution><gtr:piContribution>Formulation of protocols and studies, measurement of biochemical molecules involved in bone and calcium metabolism, writing and reviewing manuscripts, contribution to grant applications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medical Sciences Aberdeen</gtr:department><gtr:description>Role of Vitamin D and bone turnover in bone metabolism in postmenopausal women</gtr:description><gtr:id>1D15BAB7-6C30-44F4-A091-B5C72C92E858</gtr:id><gtr:impact>Student dissertations , MScs and BScs x4, Peer reviewed publications, review articles , letters in learned journals, grant awards, guideline development.</gtr:impact><gtr:outcomeId>5464992d301cc4.18876897-1</gtr:outcomeId><gtr:partnerContribution>Generation of study ideas and protocols, recruitment of subjects, radiological measurements, sampling of subjects, writing and review of manuscripts, contribution to grant applications</gtr:partnerContribution><gtr:piContribution>Formulation of studies, measurement of calcium and bone related markers/hormones related to bone metabolism, writing and review of manuscripts, contribution to grant applications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ministry of Defence (MOD)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Assessment of vitamin D status and bone metabolism in Army Recruits, effects on stress fracture outcomes</gtr:description><gtr:id>46FA309D-5831-45D7-850F-BB7CEB99061F</gtr:id><gtr:impact>Shared PhD students X4, 2 awarded 2 on-going, peer reviewed publications, guideline production, further collaborations and expansion of work.</gtr:impact><gtr:outcomeId>54648a74bd7db3.54899659-1</gtr:outcomeId><gtr:partnerContribution>Design of experiments and protocols, recruitment of volunteers, supervision of sample collection/processing, performance of radiological measurements, writing and reviewing of articles, formulation of guidance on nutrition and training programmes.</gtr:partnerContribution><gtr:piContribution>Design of experiments and clinical trials, measurement of vitamin D by tandem MS and markers of calcium and bone metabolism, writing and review of manuscripts, writing of review articles, formulation of guidance on nutrition and training programmes for MOD.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Paget's Association AGM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>33229F3F-D8A9-4F0C-A555-F8FC202A2D7F</gtr:id><gtr:impact>90 patients attended the AGM and listened to talks on Pagets disease and treatment. QA sessions were held after every talk. I gave keynote lecture and chaired subsequent sessions.

Patient contact with association increased especially from those with the disease who were not members of the association. Patient referral to outpatient clinics increased signifcantly.</gtr:impact><gtr:outcomeId>QL2by1zXgS4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Trustee Action Arthritis</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4FC7D784-BA3E-48B6-AA75-F496A7855F43</gtr:id><gtr:impact>Provision of regional grant awards to research groups. Provision of information to patients

Research performed, Knowledge enhanced , grant applications enabled.</gtr:impact><gtr:outcomeId>54649cbc63ece0.10724529</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.actionarthritis.org</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Trustee Paget's Association</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EF0EBF66-681B-4311-9305-687C6B7D286B</gtr:id><gtr:impact>Quarterly Meetings to help run the Pagets Association

Grant awards reviewed annuallya nd provided to a total of &amp;pound;150K. Spreading of Information regarding pagets association amongst patients.</gtr:impact><gtr:outcomeId>qhzE8RbxvoA</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>94340</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARC</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>69D3E002-A6BB-4326-BE68-B3E74A7F2212</gtr:id><gtr:outcomeId>pEim99fDFe80</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>483127</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/ARC reactive funding</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>30F0E691-2572-43F4-9EA0-7C67282E549B</gtr:id><gtr:outcomeId>si93RRTwy8z0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The deveopment of an assay for OPG Ab and the granting of patents for the clinical use of OPG Ab</gtr:description><gtr:grantRef>G0801462</gtr:grantRef><gtr:id>44813CAD-C8D2-4711-BF4C-85C21774AE7B</gtr:id><gtr:impact>Further publications and grant awards (NOS)</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>ahXuSpJ63jp</gtr:outcomeId><gtr:protection>Patent granted</gtr:protection><gtr:title>OPG Ab assay and clinical application of OPG Ab</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Nice Guideline on Osteoporosis</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CA378E1A-378E-412B-8DB5-316EC5EF2373</gtr:id><gtr:impact>Prescribing practice altered for osteoporosis with recommendations based on thereapeutic efficacy and economic outcomes.</gtr:impact><gtr:outcomeId>UcHHEUCfswJ</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NOS Guideline on Vitamin D</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>417B55D4-F61C-442A-9C68-61A2D63E0B78</gtr:id><gtr:impact>The guideline was directed at healthcare professionals particularly giving guidance to primary care physicians on the role of vitamin D in health and disease. The objective was to improve understanding of vitamin D indicating the value of correct requesting of 25OHD, measurement, interpretation of 25OHD results and the optimal prescribing of vitamin D to result in improved health outcomes.</gtr:impact><gtr:outcomeId>54649e47e049b9.05199271</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NOS Practical Guideline on Vitamin D</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4785DE8C-615E-4A94-B5A8-ACDA7CF43EE9</gtr:id><gtr:outcomeId>j71Z8bs98EG</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Secretary for State Seminar</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0841ED86-E997-4AA8-88F8-EB588F783E6C</gtr:id><gtr:outcomeId>eYW2j5DMBE6</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>It has become clear from the biochemical measurements in this study that the clinical symptoms are often completely dissociated from the biochemical response and that intensive therapy as given within the Trial whilst markedly affecting biochemical outcomes has far less significance in clinical outcomes.</gtr:description><gtr:id>1BBAB627-28C6-4E14-8001-70B67FE8AEB8</gtr:id><gtr:impact>The requirement to give intensive costly bisphosphonate therapy of the sort used in this trial is now questioned. The follow up study PRISM EZ has indicated a lack of a benefit of zoledronate. A manuscript has been submitted outlining the lack of benefit of Intensive therapy in Paget's Disease and the detrimental effects of an approach guided solely by biochemical measurements..</gtr:impact><gtr:outcomeId>gGifvTqtLrk</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Health Intervention</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Plasma/serum and urine samples. Expansion of analysis of both PRISM and PRISM-EZ samples. Supply of data to Edinburgh University for analysis</gtr:description><gtr:id>AFB4A218-5549-4373-A707-A0D341DDA434</gtr:id><gtr:impact>Under analysis currently.</gtr:impact><gtr:outcomeId>NKdDgrW87xp</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PRISM and PRISM EZ expansion of bone marker database</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Immunassay on an automated platform.</gtr:description><gtr:id>3B1E4C86-BBE1-4ADF-9903-0C21D06D027C</gtr:id><gtr:impact>The new assay is more convenient to use and gives different inforation within this patient group. Other measurements in several different disease states have been performed expanding the utility of this methodology.</gtr:impact><gtr:outcomeId>aruWZYLzYN3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>P1NP Assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Baseline biochemical data has been generated on all subjects in the Trial, PRISM samples have all been measured and entered into database. Correlation with outcome following treatment is now being assessed. Further assays have been performed utilising the Samples and the Database.</gtr:description><gtr:id>71E474E7-315A-45A3-8DDF-4F56A7843E40</gtr:id><gtr:impact>It is now clear that certain assays are of minimal value in this patient cohort and further measurements will not be made of TRAP5b and RANKL in this population. P1NP has shown increasing value and now MCSF has been measured in the cohort. The baseline data and samples have been utilised to validate a new Tandem MS /MS assay for deoxypyridinoline and pyridinoline.</gtr:impact><gtr:outcomeId>HmHtqc1e34L</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Baseline Pagets Data</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Serum/Plasma samples stored and categorised at UEA Bio-bank</gtr:description><gtr:id>6B973F79-1BF3-42AE-8079-32CE98B85A31</gtr:id><gtr:impact>Publications and additional grant awards</gtr:impact><gtr:outcomeId>LP7BRcAtvPu</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Outcome data for PRISM and PRISM-EZ</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>New assay for measurement of Sclerostin in serum/plasma</gtr:description><gtr:id>616795E2-4E4E-443F-AD4D-07061AB3205C</gtr:id><gtr:impact>Description of circadian rhythm and its importance in interpretation of results, measurement in high bone mass patients and in Paget's disease (under analysis)</gtr:impact><gtr:outcomeId>Z3CsbqdjssN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Sclerostin assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>38418E39-7776-4310-9D77-AA56D5D65193</gtr:id><gtr:title>Effect of recovery duration between two bouts of running on bone metabolism.</gtr:title><gtr:parentPublicationTitle>Medicine and science in sports and exercise</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c73bde4f8b909d592eb78d939e7a03f"><gtr:id>4c73bde4f8b909d592eb78d939e7a03f</gtr:id><gtr:otherNames>Scott JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-9131</gtr:issn><gtr:outcomeId>5464955567aff3.79964538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4767A49-224B-4CDB-916F-DEC4039B5AE7</gtr:id><gtr:title>Association of serum 25-hydroxyvitamin D3 and D2 with academic performance in childhood: findings from a prospective birth cohort.</gtr:title><gtr:parentPublicationTitle>Journal of epidemiology and community health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/798059b7ed602c469e4612c56b01fe3a"><gtr:id>798059b7ed602c469e4612c56b01fe3a</gtr:id><gtr:otherNames>Tolppanen AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0143-005X</gtr:issn><gtr:outcomeId>5464940d5c6da6.10118332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA3BFF46-299A-419D-8657-1F8D2D840ED3</gtr:id><gtr:title>Effect of fasting versus feeding on the bone metabolic response to running.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c73bde4f8b909d592eb78d939e7a03f"><gtr:id>4c73bde4f8b909d592eb78d939e7a03f</gtr:id><gtr:otherNames>Scott JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>5464940e217413.81176280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C97D9AE5-3C21-4B97-899B-38AB3B7D00FD</gtr:id><gtr:title>The association of 25-hydroxyvitamin D3 and D2 with behavioural problems in childhood.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/798059b7ed602c469e4612c56b01fe3a"><gtr:id>798059b7ed602c469e4612c56b01fe3a</gtr:id><gtr:otherNames>Tolppanen AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5464940d7d3330.28850005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37AB099C-601E-4EEC-BA44-FF590A1A3853</gtr:id><gtr:title>Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/628381bad26bfa7f551e71a4f76aab58"><gtr:id>628381bad26bfa7f551e71a4f76aab58</gtr:id><gtr:otherNames>Bonilla C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>54649556513034.43367891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2889781-1732-4BF5-94AA-87B2FEB008BF</gtr:id><gtr:title>Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/201eab7074e2d7637267ee601f71d550"><gtr:id>201eab7074e2d7637267ee601f71d550</gtr:id><gtr:otherNames>Langston AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>pm_16535_15_19580457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C82E5CAA-425F-4BFC-AFE3-D6192253C5E3</gtr:id><gtr:title>National Osteoporosis Society vitamin D guideline summary.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99ba78b40db3b3f927ebb6b81144b1bd"><gtr:id>99ba78b40db3b3f927ebb6b81144b1bd</gtr:id><gtr:otherNames>Aspray TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>546496c68098c6.65489745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1E4108A-20A3-4302-BCAF-75702CC05D14</gtr:id><gtr:title>Assessment of vitamin D concentration in non-supplemented professional athletes and healthy adults during the winter months in the UK: implications for skeletal muscle function.</gtr:title><gtr:parentPublicationTitle>Journal of sports sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e165977b8e2e6ad451a2cff5e9dc81c"><gtr:id>8e165977b8e2e6ad451a2cff5e9dc81c</gtr:id><gtr:otherNames>Close GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-0414</gtr:issn><gtr:outcomeId>5464940e46a436.82805769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4503C27E-1AF5-477B-AD5E-FD6388830B66</gtr:id><gtr:title>No evidence that the skeletal non-response to potassium alkali supplements in healthy postmenopausal women depends on blood pressure or sodium chloride intake.</gtr:title><gtr:parentPublicationTitle>European journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8b0b0327c42b4f62fd2c6f0182bc2ee"><gtr:id>c8b0b0327c42b4f62fd2c6f0182bc2ee</gtr:id><gtr:otherNames>Frassetto LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0954-3007</gtr:issn><gtr:outcomeId>5464940e6d56d4.44665436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35CDB41B-E6F3-4380-B039-42D9AB99D091</gtr:id><gtr:title>Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe2284a905df1936f472c417f5fd697"><gtr:id>0fe2284a905df1936f472c417f5fd697</gtr:id><gtr:otherNames>Williams DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5464940d153281.67466343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5290E79-C0AF-486E-966C-55E7C3664CC1</gtr:id><gtr:title>Vitamin D status and ill health.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/335ad8fecaf51484c663f29e4da7fc5e"><gtr:id>335ad8fecaf51484c663f29e4da7fc5e</gtr:id><gtr:otherNames>Macdonald HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>546496c61a25a2.83871230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4B14795-FEF4-4677-BD4C-9F0BEE22E11B</gtr:id><gtr:title>Associations of circulating calcium and 25-hydroxyvitamin D with glucose metabolism in pregnancy: a cross-sectional study in European and South Asian women.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f642b83060ea3340a4debdab640b312d"><gtr:id>f642b83060ea3340a4debdab640b312d</gtr:id><gtr:otherNames>Whitelaw DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>546496c576c758.55674030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>830FCDC1-0D06-4735-B625-10908D14E2D0</gtr:id><gtr:title>Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2e25a4fa01d4e26232388505f7d2e49"><gtr:id>c2e25a4fa01d4e26232388505f7d2e49</gtr:id><gtr:otherNames>Patel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0914-8779</gtr:issn><gtr:outcomeId>546492153075e8.44844234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A1F85F3-250D-4D00-B546-1F60E7E75996</gtr:id><gtr:title>Clinical Outcome With Long-term Bisphosphonate Therapy In Paget's Diseaseof Bone . The PRISM -EZ Study.</gtr:title><gtr:parentPublicationTitle>ASBMR Annual Meeting JBMR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e4fe6521dd4795580b9db37e3a94ce0"><gtr:id>0e4fe6521dd4795580b9db37e3a94ce0</gtr:id><gtr:otherNames>Goodman Kirsteen</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>HCZRPQKgT7x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CCA07C3-02DB-4E85-BDA4-C9C8CF78C376</gtr:id><gtr:title>Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5bd54cb4790776e4959982b8e578a6f"><gtr:id>c5bd54cb4790776e4959982b8e578a6f</gtr:id><gtr:otherNames>Albagha OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>54649214dc6813.73666294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD2DAFF6-223D-42A9-BBA2-D9AB2DF8752B</gtr:id><gtr:title>25-Hydroxyvitamin-D3 levels are positively related to subsequent cortical bone development in childhood: findings from a large prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6722aceae76c02d01a3b786f77f4ce70"><gtr:id>6722aceae76c02d01a3b786f77f4ce70</gtr:id><gtr:otherNames>Sayers A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0937-941X</gtr:issn><gtr:outcomeId>546492dac36c10.06038452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAEACB58-3D22-4997-851E-C0EE2876F9E3</gtr:id><gtr:title>Sunlight or diet: what is the answer for providing sufficient vitamin D in the U.K.?</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/335ad8fecaf51484c663f29e4da7fc5e"><gtr:id>335ad8fecaf51484c663f29e4da7fc5e</gtr:id><gtr:otherNames>Macdonald HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>5464921579d630.51203351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93CCAD17-769E-4D99-BCFA-E1648CCB4FED</gtr:id><gtr:title>Markers of bone health, renal function, liver function, anthropometry and perception of mood: a comparison between Flat and National Hunt Jockeys.</gtr:title><gtr:parentPublicationTitle>International journal of sports medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deb5f0f607f9a5b24127fdedd8ca5fb7"><gtr:id>deb5f0f607f9a5b24127fdedd8ca5fb7</gtr:id><gtr:otherNames>Wilson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0172-4622</gtr:issn><gtr:outcomeId>5464940e95df74.80157110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8DDA326-DFAF-4707-9AAC-1D069DDAB58F</gtr:id><gtr:title>Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/655e65ba6d998b3f12448d9ace4ca067"><gtr:id>655e65ba6d998b3f12448d9ace4ca067</gtr:id><gtr:otherNames>Wood AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5464940dd1cfe3.36877462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81D25E0F-BC10-4EE3-9B62-C961F8AC02B6</gtr:id><gtr:title>Common genetic determinants of vitamin D insufficiency: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4301c47a69ebf019636763f5b1fef74"><gtr:id>a4301c47a69ebf019636763f5b1fef74</gtr:id><gtr:otherNames>Wang TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54649215560401.16582705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1244F2D4-C964-4332-92F9-77C6B4727A65</gtr:id><gtr:title>Vitamin D and the athlete: emerging insights.</gtr:title><gtr:parentPublicationTitle>European journal of sport science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfafe053003a919fb290ed7f68c12998"><gtr:id>cfafe053003a919fb290ed7f68c12998</gtr:id><gtr:otherNames>Owens DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1536-7290</gtr:issn><gtr:outcomeId>546496c6a7d160.78111295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B40340AB-0E11-4872-8655-879C57CA26CD</gtr:id><gtr:title>Seasonal variation in 25(OH)D at Aberdeen (57&amp;deg;N) and bone health indicators--could holidays in the sun and cod liver oil supplements alleviate deficiency?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/412e368227a3af2d3b197bca1777ea9c"><gtr:id>412e368227a3af2d3b197bca1777ea9c</gtr:id><gtr:otherNames>Mavroeidi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54649555b6b294.12392031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A941C66-B282-4185-87D2-746D9E2312A6</gtr:id><gtr:title>Serum 25-hydroxyvitamin D3 and D2 and non-clinical psychotic experiences in childhood.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/798059b7ed602c469e4612c56b01fe3a"><gtr:id>798059b7ed602c469e4612c56b01fe3a</gtr:id><gtr:otherNames>Tolppanen AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5464940da21141.15414248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F3D60CF-2A38-4EC7-84B1-81AC1C68E11F</gtr:id><gtr:title>Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoring.</gtr:title><gtr:parentPublicationTitle>European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70862736759c7f4aeb94a67cf6dbe7a2"><gtr:id>70862736759c7f4aeb94a67cf6dbe7a2</gtr:id><gtr:otherNames>Gilbert R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-8278</gtr:issn><gtr:outcomeId>546495553ec095.93519217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC56B477-8EEE-41B9-BAEA-2DDDC884110A</gtr:id><gtr:title>The association of serum 25-hydroxyvitamin D3 and D2 with depressive symptoms in childhood--a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Journal of child psychology and psychiatry, and allied disciplines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/798059b7ed602c469e4612c56b01fe3a"><gtr:id>798059b7ed602c469e4612c56b01fe3a</gtr:id><gtr:otherNames>Tolppanen AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9630</gtr:issn><gtr:outcomeId>546492db1c73f5.83379559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02ECCFF9-06DF-4A13-87CC-7D523A29E534</gtr:id><gtr:title>Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.</gtr:title><gtr:parentPublicationTitle>Cancer causes &amp; control : CCC</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70862736759c7f4aeb94a67cf6dbe7a2"><gtr:id>70862736759c7f4aeb94a67cf6dbe7a2</gtr:id><gtr:otherNames>Gilbert R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0957-5243</gtr:issn><gtr:outcomeId>546492d9f3cfb3.22642059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>226CA5FE-61ED-472D-A6FA-C3739BC0D7B1</gtr:id><gtr:title>Vitamin D supplementation does not improve human skeletal muscle contractile properties in insufficient young males.</gtr:title><gtr:parentPublicationTitle>European journal of applied physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfafe053003a919fb290ed7f68c12998"><gtr:id>cfafe053003a919fb290ed7f68c12998</gtr:id><gtr:otherNames>Owens DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1439-6319</gtr:issn><gtr:outcomeId>546496c5e8d302.00823592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7F0FC08-8052-4A81-83F0-C2B5B02706FB</gtr:id><gtr:title>Risk factors for variation in 25-hydroxyvitamin D3 and D2 concentrations and vitamin D deficiency in children.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/798059b7ed602c469e4612c56b01fe3a"><gtr:id>798059b7ed602c469e4612c56b01fe3a</gtr:id><gtr:otherNames>Tolppanen AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5464940ce7c655.95270201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39B45E39-B0BD-4D30-A99C-0BF4F171EBB8</gtr:id><gtr:title>Analysis of body composition in individuals with high bone mass reveals a marked increase in fat mass in women but not men.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d19baf65a1d87a00f29f788642a9925c"><gtr:id>d19baf65a1d87a00f29f788642a9925c</gtr:id><gtr:otherNames>Gregson CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>54649555d94b75.98958788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>872788EC-5C4A-4174-8CC5-338A80256127</gtr:id><gtr:title>Treadmill running reduces parathyroid hormone concentrations during recovery compared with a nonexercising control group.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c73bde4f8b909d592eb78d939e7a03f"><gtr:id>4c73bde4f8b909d592eb78d939e7a03f</gtr:id><gtr:otherNames>Scott JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>546496c59e18b8.72442737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E33B88CC-0890-4944-A4E8-D814F9E9B980</gtr:id><gtr:title>Prospective association of 25-hydroxyvitamin d3 and d2 with childhood lung function, asthma, wheezing, and flexural dermatitis.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/798059b7ed602c469e4612c56b01fe3a"><gtr:id>798059b7ed602c469e4612c56b01fe3a</gtr:id><gtr:otherNames>Tolppanen AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn><gtr:outcomeId>546495560a7e57.47909870</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C56EC640-976A-4E33-A714-3CEB3F07C3A4</gtr:id><gtr:title>Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9a097ff13a2410ba9f26bc00c832e17"><gtr:id>f9a097ff13a2410ba9f26bc00c832e17</gtr:id><gtr:otherNames>Visconti MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>546492150c00b7.12338188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>889758E1-851F-4AF1-AF80-0670A88E4FAC</gtr:id><gtr:title>Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/335ad8fecaf51484c663f29e4da7fc5e"><gtr:id>335ad8fecaf51484c663f29e4da7fc5e</gtr:id><gtr:otherNames>Macdonald HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>54649556ece735.56937747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>541A04C5-01D9-4689-B9DE-2A7B7567F223</gtr:id><gtr:title>Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.</gtr:title><gtr:parentPublicationTitle>Cancer causes &amp; control : CCC</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70862736759c7f4aeb94a67cf6dbe7a2"><gtr:id>70862736759c7f4aeb94a67cf6dbe7a2</gtr:id><gtr:otherNames>Gilbert R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0957-5243</gtr:issn><gtr:outcomeId>5464940df3a362.92432932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77BFCE24-BDA1-45D5-9C86-18329C609A52</gtr:id><gtr:title>Skin color change in Caucasian postmenopausal women predicts summer-winter change in 25-hydroxyvitamin D: findings from the ANSAViD cohort study.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/335ad8fecaf51484c663f29e4da7fc5e"><gtr:id>335ad8fecaf51484c663f29e4da7fc5e</gtr:id><gtr:otherNames>Macdonald HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>546492da2f1747.15190719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>259C5648-A0DA-4300-9109-F4D02D82AFB1</gtr:id><gtr:title>Effect of supplementation with vitamin D2-enhanced mushrooms on vitamin D status in healthy adults.</gtr:title><gtr:parentPublicationTitle>Journal of nutritional science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab837f2fc4d6c636556ecb93122f3d08"><gtr:id>ab837f2fc4d6c636556ecb93122f3d08</gtr:id><gtr:otherNames>Stepien M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2048-6790</gtr:issn><gtr:outcomeId>546495558d6585.71026806</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AF6889B-A358-4018-93D0-436389DEB35C</gtr:id><gtr:title>Associations of maternal 25-hydroxyvitamin D in pregnancy with offspring cardiovascular risk factors in childhood and adolescence: findings from the Avon Longitudinal Study of Parents and Children.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe2284a905df1936f472c417f5fd697"><gtr:id>0fe2284a905df1936f472c417f5fd697</gtr:id><gtr:otherNames>Williams DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>546495578a9ed5.65366657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE12913E-7707-4370-AFF7-7385810DFAF1</gtr:id><gtr:title>The effects of vitamin D(3) supplementation on serum total 25[OH]D concentration and physical performance: a randomised dose-response study.</gtr:title><gtr:parentPublicationTitle>British journal of sports medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e165977b8e2e6ad451a2cff5e9dc81c"><gtr:id>8e165977b8e2e6ad451a2cff5e9dc81c</gtr:id><gtr:otherNames>Close GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0306-3674</gtr:issn><gtr:outcomeId>546495562cf282.39094073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F71DD7E7-FA1E-4B99-8415-22AA39A76E30</gtr:id><gtr:title>Dietary patterns, bone resorption and bone mineral density in early post-menopausal Scottish women.</gtr:title><gtr:parentPublicationTitle>European journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a80cfbcdb122c129908aaa6d4293839"><gtr:id>5a80cfbcdb122c129908aaa6d4293839</gtr:id><gtr:otherNames>Hardcastle AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0954-3007</gtr:issn><gtr:outcomeId>54649215e961b7.13955562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A026A3B6-D897-4459-B86B-2E4AFB74CE74</gtr:id><gtr:title>The role of exercise intensity in the bone metabolic response to an acute bout of weight-bearing exercise.</gtr:title><gtr:parentPublicationTitle>Journal of applied physiology (Bethesda, Md. : 1985)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c73bde4f8b909d592eb78d939e7a03f"><gtr:id>4c73bde4f8b909d592eb78d939e7a03f</gtr:id><gtr:otherNames>Scott JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0161-7567</gtr:issn><gtr:outcomeId>54649215c6b983.42275285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F82724A-B75D-447B-BA0A-C3EE2C0CFEF6</gtr:id><gtr:title>Does bone resorption stimulate periosteal expansion? A cross-sectional analysis of ?-C-telopeptides of type I collagen (CTX), genetic markers of the RANKL pathway, and periosteal circumference as measured by pQCT.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28628804526efe2b2fb3f23a2324943e"><gtr:id>28628804526efe2b2fb3f23a2324943e</gtr:id><gtr:otherNames>Kemp JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>546478115455c9.14723780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B72D818-62C4-4432-A7EB-2992DD36990B</gtr:id><gtr:title>Associations of childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk factors in adolescence: prospective findings from the Avon Longitudinal Study of Parents and Children.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe2284a905df1936f472c417f5fd697"><gtr:id>0fe2284a905df1936f472c417f5fd697</gtr:id><gtr:otherNames>Williams DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn><gtr:outcomeId>5464940eb735b7.18620950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5D3688F-41ED-4582-A072-454FB27F5B7B</gtr:id><gtr:title>Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5bd54cb4790776e4959982b8e578a6f"><gtr:id>c5bd54cb4790776e4959982b8e578a6f</gtr:id><gtr:otherNames>Albagha OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>5464781129ff37.30192538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E79728AD-3FE2-456A-BC68-4CCDF143E6A9</gtr:id><gtr:title>Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d19baf65a1d87a00f29f788642a9925c"><gtr:id>d19baf65a1d87a00f29f788642a9925c</gtr:id><gtr:otherNames>Gregson CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>546496c5c3a300.28115062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21554C41-66EE-4AFE-98BB-929BB21BE2CF</gtr:id><gtr:title>Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/941152cf429bd73b383849ee066ec622"><gtr:id>941152cf429bd73b383849ee066ec622</gtr:id><gtr:otherNames>Gartland A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>5464940cc44734.10445476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02ACC77F-411B-402B-B00E-F4E8725342A7</gtr:id><gtr:title>Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f49ec357097da4530e73675de2c05c3e"><gtr:id>f49ec357097da4530e73675de2c05c3e</gtr:id><gtr:otherNames>Deere K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>54649556ca0986.41842583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6A4B33E-2A57-4E16-90EB-90554F1B6059</gtr:id><gtr:title>Effect of exercise intensity on the cytokine response to an acute bout of running.</gtr:title><gtr:parentPublicationTitle>Medicine and science in sports and exercise</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c73bde4f8b909d592eb78d939e7a03f"><gtr:id>4c73bde4f8b909d592eb78d939e7a03f</gtr:id><gtr:otherNames>Scott JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0195-9131</gtr:issn><gtr:outcomeId>546492da5363a7.52792573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B90DA26F-74E3-4A35-8A1D-9A6F8427A2C4</gtr:id><gtr:title>Dietary silicon interacts with oestrogen to influence bone health: evidence from the Aberdeen Prospective Osteoporosis Screening Study.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/335ad8fecaf51484c663f29e4da7fc5e"><gtr:id>335ad8fecaf51484c663f29e4da7fc5e</gtr:id><gtr:otherNames>Macdonald HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>546492dae71560.81131037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2470EA5-7364-490A-B17B-C63EFD03C639</gtr:id><gtr:title>Birth weight is positively related to bone size in adolescents but inversely related to cortical bone mineral density: findings from a large prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e4497fc9e7881370d4b6cb78d01a858"><gtr:id>1e4497fc9e7881370d4b6cb78d01a858</gtr:id><gtr:otherNames>Steer CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>546496c649ae80.97704522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06A71CF0-BC0E-4DE3-9CBA-7808C1C08E2A</gtr:id><gtr:title>Maternal vitamin D status during pregnancy and bone-mineral content in offspring - Authors' reply.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dc0eb8b7c62f213cdc50336372e8b86"><gtr:id>4dc0eb8b7c62f213cdc50336372e8b86</gtr:id><gtr:otherNames>Lawlor DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54649557432c42.07788735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09FAD51E-D8F4-4531-A8F9-D1FFAE80B9CF</gtr:id><gtr:title>Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70862736759c7f4aeb94a67cf6dbe7a2"><gtr:id>70862736759c7f4aeb94a67cf6dbe7a2</gtr:id><gtr:otherNames>Gilbert R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>546492da9b6483.27193844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8E282AC-D1C0-4199-A7AC-C8CEB8A176AC</gtr:id><gtr:title>Maternal 25-hydroxyvitamin D and its association with childhood atopic outcomes and lung function.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a71ede2d5cc7f35b3f0c849b13246f30"><gtr:id>a71ede2d5cc7f35b3f0c849b13246f30</gtr:id><gtr:otherNames>Wills AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>5464955768e9d0.49206153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>217CA6DF-A1D6-4966-BBE2-EE40CE0251F9</gtr:id><gtr:title>Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern?</gtr:title><gtr:parentPublicationTitle>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/335ad8fecaf51484c663f29e4da7fc5e"><gtr:id>335ad8fecaf51484c663f29e4da7fc5e</gtr:id><gtr:otherNames>Macdonald HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0937-941X</gtr:issn><gtr:outcomeId>54649215a02575.37688202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>148E4CBD-7C8D-4BB9-9168-7D47D7F46518</gtr:id><gtr:title>Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Annals of nutrition &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6e417fa71be289730f6211c52932829"><gtr:id>f6e417fa71be289730f6211c52932829</gtr:id><gtr:otherNames>Hypp?nen E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0250-6807</gtr:issn><gtr:outcomeId>54649557b03238.56435802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6011600D-940C-48EF-83A4-88808DDC77EA</gtr:id><gtr:title>Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5bd54cb4790776e4959982b8e578a6f"><gtr:id>c5bd54cb4790776e4959982b8e578a6f</gtr:id><gtr:otherNames>Albagha OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>546492da778e45.32502221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>835CAE33-B383-433D-B614-368F030ACD40</gtr:id><gtr:title>A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?</gtr:title><gtr:parentPublicationTitle>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/655e65ba6d998b3f12448d9ace4ca067"><gtr:id>655e65ba6d998b3f12448d9ace4ca067</gtr:id><gtr:otherNames>Wood AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0937-941X</gtr:issn><gtr:outcomeId>546495571f2e16.02797701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DBEECBC-965A-417D-A900-E41C150057A1</gtr:id><gtr:title>Cytokine response to acute running in recreationally-active and endurance-trained men.</gtr:title><gtr:parentPublicationTitle>European journal of applied physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c73bde4f8b909d592eb78d939e7a03f"><gtr:id>4c73bde4f8b909d592eb78d939e7a03f</gtr:id><gtr:otherNames>Scott JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1439-6319</gtr:issn><gtr:outcomeId>54649556776574.52807752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3D69CF8-53C1-4190-9D3A-A555DB908C9B</gtr:id><gtr:title>Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dc0eb8b7c62f213cdc50336372e8b86"><gtr:id>4dc0eb8b7c62f213cdc50336372e8b86</gtr:id><gtr:otherNames>Lawlor DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54649556a47054.37465478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0FD61A2-2A9A-45AF-BAD1-B14FDDF1EF9F</gtr:id><gtr:title>Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment study.</gtr:title><gtr:parentPublicationTitle>Cancer causes &amp; control : CCC</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70862736759c7f4aeb94a67cf6dbe7a2"><gtr:id>70862736759c7f4aeb94a67cf6dbe7a2</gtr:id><gtr:otherNames>Gilbert R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0957-5243</gtr:issn><gtr:outcomeId>5464940d382390.47289416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35F0FDCE-BAFE-485E-9C12-0B16FECE7559</gtr:id><gtr:title>LC-MS/MS Measurement of urine free collagen crosslinks pyridinoline and deoxypyridinoline:urine markers of bone resorption</gtr:title><gtr:parentPublicationTitle>Journal of Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f266c5de1e93507f08d86a8b7da2032d"><gtr:id>f266c5de1e93507f08d86a8b7da2032d</gtr:id><gtr:otherNames>Tang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546483d5b66867.18802898</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801462</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>